文献速递帕金森病与运动障碍

帕金森病丘脑底核刺激长期运动结局的预测因素

Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease.
PubMed 文献 · Ann Neurol · 2021-01-09

该研究纳入1993至2015年法国格勒诺布尔大学医院连续接受双侧丘脑底核深部脑刺激的帕金森病患者,分析术前预测长期运动结局的因素。长期分析纳入138例(平均随访8.4±6.26年),发现术前较高额叶评分和停药MDS-UPDRS第三部分评分预测更好的长期运动反应,神经影像血管改变预测更差结局。短期分析纳入357例,术前左旋多巴反应、震颤主导型、基线额叶评分和停药MDS-UPDRS第三部分评分预测短期运动结局。

要点

  • 术前较高额叶评分和停药MDS-UPDRS第三部分评分预测更好的长期运动反应。
  • 神经影像显示血管改变预测更差的长期运动结局。
  • 短期运动结局由术前左旋多巴反应、震颤主导型、额叶评分和停药MDS-UPDRS第三部分评分预测。

核心结论

  • 额叶功能障碍、停药状态疾病严重程度和神经影像血管改变是丘脑底核深部脑刺激长期运动效应的主要术前临床预测因素。

研究设计与样本

  • 研究为回顾性队列分析,纳入1993至2015年法国格勒诺布尔大学医院连续接受双侧丘脑底核深部脑刺激的帕金森病患者。
  • 长期分析纳入138例,平均随访8.4±6.26年,中位10年,范围1-17年;短期分析纳入357例有1年随访数据的患者。
  • 采用生存分析及单因素/多因素Cox回归分析长期预测因素,采用单因素/多因素线性回归分析短期预测因素。

主要发现

  • 长期分析中,术前较高额叶评分和停药MDS-UPDRS第三部分评分预测更好的长期运动反应。
  • 长期分析中,神经影像存在血管改变预测更差的运动结局。
  • 短期分析中,术前左旋多巴反应、震颤主导型、基线额叶评分和停药MDS-UPDRS第三部分评分预测短期运动结局。

关键数值与推荐

  • 长期运动获益丧失定义为与基线停药MDS-UPDRS第三部分评分相比,刺激后评分改善不足25%。

临床怎么用

  • 术前评估额叶功能、停药状态运动严重程度及神经影像血管改变,有助于预判丘脑底核深部脑刺激的长期运动结局。
  • 术前左旋多巴反应、震颤主导型、额叶评分和停药MDS-UPDRS第三部分评分可用于预判短期运动结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to identify preoperative predictive factors of long-term motor outcome in a large cohort of consecutive Parkinson disease (PD) patients with bilateral subthalamic nucleus deep brain stimulation (STN-DBS). METHODS: All consecutive PD patients who underwent bilateral STN-DBS at the Grenoble University Hospital (France) from 1993 to 2015 were evaluated before surgery, at 1 year (short-term), and in the long term after surgery. All available demographic variables, neuroimaging data, and clinical characteristics were collected. Preoperative predictors of long-term motor outcome were investigated by performing survival and univariate/multivariate Cox regression analyses. Loss of motor benefit from stimulation in the long term was defined as a reduction of less than 25% in the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III scores compared to the baseline off-medication scores. As a secondary objective, potential predictors of short-term motor outcome after STN-DBS were assessed by performing univariate and multivariate linear regression analyses. RESULTS: In the long-term analyses (mean follow-up = 8.4 ± 6.26 years, median = 10 years, range = 1-17 years), 138 patients were included. Preoperative higher frontal score and off-medication MDS-UPDRS part III scores predicted a better long-term motor response to stimulation, whereas the presence of vascular changes on neuroimaging predicted a worse motor outcome. In 357 patients with available 1-year follow-up, preoperative levodopa response, tremor dominant phenotype, baseline frontal score, and off-medication MDS-UPDRS part III scores predicted the short-term motor outcome. INTERPRETATION: Frontal lobe dysfunction, disease severity in the off-medication condition, and the presence of vascular changes on neuroimaging represent the main preoperative clinical predictors of long-term motor STN-DBS effects. ANN NEUROL 2021;89:587-597.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Cavallieri F, Fraix V, Bove F, et al. Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease. Ann Neurol. 2021. PMID: 33349939. doi:10.1002/ana.25994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。